Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Sales | 2,475 | 1,181 | 680 | 510 | 50 |
| Gross Profit | 2,475 | 1,181 | 680 | 510 | 50 |
| Operating Expenses | 15,217 | 5,747 | 5,830 | 5,300 | 5,580 |
| Operating Income | -12,742 | -4,566 | -5,150 | -4,790 | -5,530 |
| Interest Expense | -551 | -60 | 0 | 0 | 0 |
| Other Income | 0 | 0 | 340 | 250 | 140 |
| Pre-tax Income | -12,191 | -4,506 | -4,810 | -4,540 | -5,390 |
| Income Tax | N/A | N/A | 0 | 0 | 90 |
| Net Income Continuous | -12,191 | -4,506 | -4,810 | -4,540 | -5,480 |
| Net Income | $-12,191 | $-4,506 | $-4,810 | $-4,540 | $-5,490 |
| EPS Basic Total Ops | -12.80 | -6.20 | -7.77 | -8.32 | -11.04 |
| EPS Basic Continuous Ops | -12.82 | -6.21 | -7.77 | -8.32 | -11.02 |
| EPS Diluted Total Ops | -12.80 | -6.20 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -12.82 | -6.21 | N/A | N/A | N/A |
| EBITDA(a) | $-12,148 | $-4,184 | $-4,870 | $-4,540 | $-5,210 |